Logo - springer
Slogan - springer

Biomedical Sciences - Neuroscience | Molecular Neurodegeneration (Editorial Board)

Molecular Neurodegeneration

Molecular Neurodegeneration

Editor-in-Chief: Huaxi Xu
Editors-in-Chief: Guojun Bu

ISSN: 1750-1326 (electronic version)

Journal no. 13024

BioMed Central

Open access BioMed Central

Editors-in-Chief
Guojun Bu, Mayo Clinic, USA
Huaxi Xu, Sanford Burnham Prebys Medical Discovery Institute, USA

Senior Editors
Hongmei Li, Mayo Clinic, USA
Henrietta M Nielsen, Stockholm University, Sweden

Associate Editors
Abbot F Clark, University of North Texas Health Science Center, USA
Mark R Cookson, National Institutes of Health, USA
Ted Dawson, The John Hopkin's University School of Medicine, USA
Steven Estus, University of Kentucky, USA
Sam Gandy, Mount Sinai School of Medicine, USA
Todd E Golde, University of Florida, USA
David Holtzman, Washington University School of Medicine, USA
Edward Koo, University of California, San Diego, USA
Gopal Thinakaran, University of Chicago, USA
Robert Vassar, Northwestern University Medical School, USA
Hui Zheng, Baylor College of Medicine, USA

Editorial Board
Don Cleveland, University of California San Diego, USA
Luciano D'Adamio, Albert Einstein College of Medicine, USA
Bart De Strooper, K.U. Leuven University, Belgium
Aaron D Gitler, Stanford University School of Medicine, USA
Charles Glabe, University of California, Irvine, USA
Michel Goedert, MRC Laboratory of Molecular Biology, UK
Cheng-Xin Gong, New York State Institute for Basic Research, USA
Bradley Hyman, Massachusetts General Hospital, USA
Nibaldo C Inestrosa, Pontificia Universidad Catolica de Chile, Chile
Takeshi Iwatsubo, University of Tokyo, Japan
Mathias Jucker, University of Tubingen, Germany
Seung Hyun Kim, Hanyang University, South Korea
Jeffrey Kordower, Rush University Medical Center, USA
Mary Jo LaDu, University of Illinois at Chicago, USA
Francesca-Fang Liao, University of Tennessee, USA
Xiao-Jiang Li, Emory University School of Medicine, USA
Stefan Lichtenthaler, Technische Universität München, Germany
Stuart Lipton, The Scripps Research Institute, USA
María Paz Marzolo, Pontificia Universidad Católica de Chile, Chile
Colin Masters, The University of Melbourne, Australia
Pamela J McLean, Mayo Clinic, USA
Kevin Morgan, University of Nottingham, UK
Karen O'Malley, Washington University School of Medicine, USA
Harry Orr, University of Minnesota, USA
Leonard Petrucelli, Mayo Clinic, USA
Lawrence Rajendran, University of Zurich, Switzerland
G. William Rebeck, Georgetown University, USA
Owen Ross, Mayo Clinic, USA
Jie Shen, Harvard Medical School, USA
Sangram Sisodia, University of Chicago, USA
Nuno Sousa, University of Minho, Portugal
James Surmeier, Northwestern University, USA
Rudolph Tanzi, Massachusetts General Hospital East, USA
Marcel M Verbeek, Radboud University Nijmegen Medical Centre, The Netherlands
Philip C. Wong, The Johns Hopkins University School of Medicine, USA
Tony Wyss-Coray, Stanford University, USA
William Yang, David Geffen School of Medicine at UCLA, USA
Yun-wu Zhang, Xiamen University, China
Xiongwei Zhu, Case Western Reserve University, USA
Berislav Zlokovic, University of Southern California, USA

Read This journal on BioMed Central

For authors and editors


  • Journal Citation Reports®
    2016 Impact Factor
  • 6.780
  • Aims and Scope

    Aims and Scope

    Close

    Molecular Neurodegeneration is an open access, peer-reviewed journal that encompasses all aspects of neurodegeneration research at the molecular and cellular levels.

    Neurodegenerative diseases collectively refer to neurological disorders that result from neurodegeneration and include, but are not limited to, Alzheimer's disease, Parkinson's disease, Huntington's disease, and prion diseases. These diseases, which are often associated with advanced aging and display varying degrees of dementia, have become a significant public health issue as humans live longer and the aging population grows larger. Recent advances in the molecular and cellular mechanisms underlying the pathogenesis of these neurodegenerative disorders have allowed for a better understanding of the disease mechanisms.

  • Submit Online
  • English Language Editing

    English Language Editing

    Close

  • Writing Resources: Training for Authors